HIV continues to be the epidemic of our lifetime. Even today, 2 million new infections occur worldwide and there are over 50,000 new cases a year in the US. Developing an HIV vaccine has been a scientific challenge, but new technologies and approaches are leading to guarded optimism about achieving this goal. Dr. Lawrence Corey, professor of medicine and laboratory medicine at the University of Washington, past president of the Fred Hutchinson Cancer Research Center, and head of the HIV Vaccine Trials Network, will discuss the state of the HIV vaccine field and the role Seattle plays in this field.
Lawrence Corey, MD, professor, Departments of Medicine and Laboratory Medicine, adjunct professor, Departments of Pediatrics and Microbiology, University of Washington
03/30/2016
[ Ссылка ]
[ Ссылка ]
